• About us
• Contact

Advertisement

Organisation › Details

Techne Corporation (Nasdaq: TECH) (d/b/a Bio-Techne)

Techne Corporation (d/b/a Bio-Techne), NASDAQ: TECH, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With over 24,000 products in its portfolio, Bio-Techne generated approximately $311 million in net sales in fiscal year 2013 and has over 1,000 employees worldwide. *

 

	Start	1993-07-30 existent
	End	2014-11-01 renamed
	Group	Bio-Techne (Group)
	Today	Bio-Techne Corporation (Nasdaq: TECH)
	Successor	Bio-Techne Corporation (Nasdaq: TECH)
	Industry	diagnostics (medical/biological)
	Industry 2	reagents (bio/biochemical)
	Person	Kummeth, Charles R. (Chuck) (Techne Corp 201304– CEO before Thermo Fisher 201204 Pres Chromatography + MS + 3M Medical)
	Region	Minneapolis, MN
	Country	United States (USA)
	Street	614 McKinley Place NE
	City	55413-2610 Minneapolis, MN
	Tel	+1-612-379-8854
		Address record changed: 2020-12-02
Basic data	Employees	E: 501 to 1,000 (2014-06-17)
	Currency	USD
	Annual sales	311,000,000 (net sales (2013FY) 2013-12-31)
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Bio-Techne (Group)

• [1] Lunaphore Technologies S.A.. (6/22/23). "Press Release: Lunaphore to Get Acquired by Bio-Techne". Tolochenaz & Minneapolis, MN....
• [2] Lunaphore Technologies S.A.. (4/17/23). "Press Release: Bio-Techne and Lunaphore Establish Strategic Partnership to Develop the First Fully Automated Same-slide Spatial Multiomics Solution". Minneapolis, MN & Lausanne....
• [3] Lunaphore Technologies S.A.. (3/23/23). "Press Release: Lunaphore Raises CHF40M in the First Close of Series D Funding Led by EGS Beteiligungen AG". Lausanne....
• [4] |transkript [gkä, Kääb, Georg]. (10/26/21). "News: Aus für Exosome Diagnostics in Martinsried"....
• [5] Lunaphore Technologies S.A.. (5/13/21). "Press Release: Lunaphore Announces Appointment of Matthias Weber, former President of Leica Biosystems, to Board of Directors". Lausanne....
• [6] Lunaphore Technologies S.A.. (6/15/20). "Press Release: Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat Research". Portsmouth, NH & Lausanne....
• [7] Lunaphore Technologies S.A.. (4/21/20). "Press Release: Lunaphore Receives Additional CHF 2M in Series C2 Financing, Bringing Total Series C Round to CHF 25M". Lausanne....
• [8] Lunaphore Technologies S.A.. (2/6/20). "Press Release: Lunaphore Receives CHF 23M Series C Financing, Led by PHC Holdings Corporation". Lausanne....
• [9] Lunaphore Technologies S.A.. (8/30/19). "Press Release: Lunaphore Appoints Joseph Bernardo as New Chairman of the Board". Lausanne....
• [10] Lunaphore Technologies S.A.. (6/10/19). "Press Release: Cartana, Lunaphore and Stockholm University Collaborate on Automated Next Generation In Situ Sequencing". Stockholm & Lausanne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.